Biotage
165.5 SEK +0.49%Be the first to follow this company
Biotage is active in biotechnology. The company provides solutions in chromatography, organic synthesis, and sample preparation. The company has operations on a global level, mainly concentrated in Europe, North America, and Asia, and a large part of the projects are also conducted in collaboration with other players in the said market. Customers are found in health and care, as well as in the food industry.
Revenue
1.86B
EBIT %
16.86 %
P/E
49.55
Dividend yield-%
0.97 %
Target price
-
Recommendation
-
Updated
-
NASDAQ Stockholm
BIOT
Daily low / high price
156.2 / 167.1
SEK
Market cap
13.35B SEK
Turnover
48.48M SEK
Volume
297K
Latest videos
Financial calendar
Interim report
2024-07-16
Interim report
2024-10-23
Annual report
2025-02-19
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Gamma Biosciences | 16.9 % | 17.0 % |
SEB Fonder | 7.6 % | 7.7 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Beslut vid årsstämma i Biotage AB den 25 april 2024
Resolutions at the Annual General Meeting in Biotage AB on April 25, 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools